PÜR LIFE Medical - Woodbury
PÜR LIFE Medical - Woodbury · 116 Woodbury Road · Woodbury, NY 11797
4.9· 60 Google reviews
Listing updated October 2, 2026
No current plans confirmed — RetaMaps has not yet confirmed this practice's intentions regarding retatrutide. Inclusion on RetaMaps does not mean the provider offers or will offer retatrutide.
Care described on the practice's website
- Medically supervised weight loss
About this practice
PÜR LIFE Medical in Woodbury, New York is a practice whose website describes bringing regenerative healthcare to its community, with red light therapy, hormone replacement, aesthetic services and weight-loss programs, and says it aims to address root causes with personalized treatments. The site describes semaglutide injections as part of its weight-loss offerings. On Google it holds a 4.9-star rating across 60 reviews dating back to 2025, with 7 posted in the past year; reviewers most often mention the staff (6 reviews), with 2 mentioning results.
Services & access
| Advertises semaglutide today | Not listed |
| Advertises tirzepatide today | Not listed |
| Telehealth visits | Not listed |
| Cash pay accepted | — |
| Accepts insurance — per practice website | Yes |
| Accepting new patients — per practice website | Yes |
"Not listed" means we didn't find this stated on the practice's public pages — it doesn't mean no. — means unknown. Medication rows describe currently FDA-approved GLP-1 medications the practice advertises today, not retatrutide. Confirm details directly with the practice.
Review activity
Counts computed by RetaMaps from public Google reviews; most recent review 2026-08-18. Read the reviews themselves on the practice's Google listing.
What patients say
Rated ★4.9 across 60 Google reviews. Of the 15 reviews we analyzed, 15 (100%) are positive (4–5★) and 0 (0%) are negative (1–2★).
What patients like
- Friendly, helpful staff6 reviews
- Weight-loss results2 reviews
- Clean, comfortable office2 reviews
Common complaints
No negative reviews among those we analyzed.
Most recent Google reviews
Kristin G.★★★★★2026-07-21Angelene is an absolute doll and knows exactly how to treat my needs as it relates to my Dysport total dosing and overall treatment areas. The office is spotless and all staff never anything less than top tier support and kindness.
Sydney L.★★★★★2026-07-14Sue and her incredible team at the front desk, NPs and beyond are always kind, friendly and downright loving! They truly care about your experience and outcome, and for a crazy busy gal like myself who can only come on off hours, they always accommodate my schedule. Wouldn’t go anywhere else!
Marina N.★★★★★2026-07-01I love this place, they've helped me a lot with weight loss, and the staff is very friendly and efficient.
Sal A.★★★★★2025-12-04I have been going to PUR LIFE Medical In Woodbury for about three months. They introduced me to the Shockwave treatment for my arthritic right elbow. They told me to be patient and after three or four sessions I should see a drastic reduction in pain. There were absolutely right on the mark. After my six treatments, my pain is reduced about 80%, which is exactly what they predicted. I had such great results that I signed up for the treatment for my left shoulder. Again, the process is going exactly as they had explained and I have a lot more mobility and less pain in my neck and shoulder blade that I’ve ever had. My Therapist Alexis is fantastic. She explains everything to me and describes exactly when I should expect during and after the treatment. She is great. The whole staff at PUR LIFE Medical In Woodbury, his friendly and professional. I would recommend this treatment and place to anyone if I can give it 10 stars I would!!!
The F.★★★★★2025-11-29Awesome!
Analysis by RetaMaps of reviews on this practice's public Google Business listing; review themes are detected automatically and reviews reflect their authors' opinions. See all reviews on Google.
Retatrutide is Eli Lilly's investigational once-weekly triple agonist (GIP, GLP-1 and glucagon receptors). Five Phase 3 trials have reported positive results, and Lilly plans to submit it to the FDA in Q1 2027. It is not FDA-approved, has no brand name or price, and cannot be prescribed outside clinical trials or Lilly's physician-requested expanded access program. Products sold online as "research" or compounded retatrutide are not legitimate retatrutide.
- Development
- Phase 3 complete
- FDA status
- Submission planned — Q1 2027 (Lilly guidance)
- Availability
- Not commercially available
- Access routes
- Clinical trials, or Lilly's expanded access program (physician must apply)
Next milestone: TRIUMPH-5 head-to-head vs tirzepatide results (Expected ~Dec 2026)
Sources: Lilly — What to know about retatrutide · Lilly — TRIUMPH-2/TRIUMPH-3 results · BioPharma Dive — FDA submission plans · STAT — Lilly expanded access (Aug 3, 2026) · FDA — Concerns with unapproved GLP-1 drugs